Global Next Generation Sequencing Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

November 2017 | 210 pages | ID: G4FE933CB79EN
Precision Business Insights (PBI)

Abstracts

Next-generation sequencing is the process of sequencing DNA strands similar to the nucleotides in a DNA molecule. Next-generation sequencing is carried by massive parallelization. Next-generation sequencing reduces the requirements for the fragment-cloning method used in sequencing of the genomes by Sanger’s method. Due to high accuracy, precise results, and low cost, and with low sample, next-generation sequencing is preferred over the Sanger’s method. It is commonly used in oncology studies, biomarker discovery, agricultural and animal research, personalized medicine, and others. In addition, re-sequencing of targets, identification of binding sites of a transcriptional factor, and non-coding RNA expression profiling are other applications of next-generation sequencing.

Next-generation sequencing market is driven by technological development in next-generation sequencing, increase in the various applications, decreasing the cost of sequencing, increase in gene mapping programs, increasing automation for pre-sequencing programs, and development of personalized medicine which are expected to fuel the next generation sequencing market. Moreover, rise in R&D activities by the market players and drug discovery applications are driving the demand for next-generation sequencing (NGS) market. However, lack of skilled professionals, ethical and legal issues in the interpretation, storage and management of patient data, and high reliability on funding from the government might hamper the next generation sequencing market over the forecast period.

The next generation sequencing market segmented based on the product and service type, technology, application type, and end user

Based on the product and service type, the next-generation sequencing market segmented into the following:

• Pre-sequencing products and services market
• DNA fragmentation, size selection, A-tailing, and end repair
• Library preparation and target enrichment
• Quality control
• Sequencing services market
• Targeted sequencing/gene panels
• RNA-Seq
• De Novo sequencing
• Exome sequencing
• Chip-Seq
• Whole-genome sequencing
• Methyl-Seq
• Others

Next-generationn sequencing, data analysis, storage, and management (Bioinformatics) market

• NGS data analysis software & workbenches
• NGS data analysis services
• NGS storage management and cloud computing solutions

Based on technology, the next-generation sequencing market segmented into the following:

• Ion semiconductor sequencing
• Sequencing by the synthesis (SBS)
• Nanopore sequencing
• Single-molecule real-time (SMRT) sequencing

Based on application, the next-generation sequencing market segmented into the following:

• Drug discovery
• Diagnostics
• Agriculture and animal research
• Biomarker discovery
• Precision medicine
• Other applications

Based on the end-user, the next-generation sequencing market segmented into the following:

• Biotechnology and Pharmaceutical Companies
• Research Centres
• Hospitals & Clinics
• Others

The global next-generation sequencing market is in growing stage, several local and international players are actively involved in the development and marketing of global next-generation sequencing market. Organizations are focusing on the introduction of low-cost sequencing devices in routine medical check-ups. For instance, Grail is focusing on the development of a next generation sequencing technology that allows detection of different types of cancer before the symptoms appear. This test is expected to reach the market by 2019. Furthermore, companies are also engaged in producing genomic data by making it available to research laboratories worldwide. Growing partnerships, collaborations, increasing adoption of NGS among research laboratories and academic institutes, and the launch of services and novel products by market players fuel the growth of global next generation sequencing market over the forecast period. Moreover, increase in inclination of drug developers and scientists towards the next generation sequencing technology for the development of personalized medicine is a key driver for the demand of next generation sequencing platforms for gaining insights into the genetic organization.

Next-generation sequencing market segmented into following regions Viz. North America, Asia-Pacific, Latin America, Europe, and Middle East and Africa. North America expected to hold a major share, which is attributed to rise in adoption of next generation sequence, development in the healthcare infrastructure, decrease in the cost, and increase in the R&D activities for proteomic and genomic sequence determination. Moreover, most of the end users for clinical and academic use are from the U.S., U.K., and Germany due to presence of universities offering molecular biology course in these regions might bolster the next generation sequencing market. For instance, in June 2015, Illumina has opened its Europe headquarters in the Cambridge to increase its revenue through 10,000 genome project carried out in U.K. Asia-Pacific is expected to grow at the fastest rate in global next generation sequencing market with owing to increasing investment in development in healthcare expenditure, rising medical awareness in regional population, government funding for translational research, and rising partnerships & agreements among market players. In addition, these countries have less-stringent regulations and data requirements as compared to developed nations; companies find regulatory policies in the Asia-Pacific region to be adaptive and business-friendly.

Some of the players in global next-generation sequencing market are Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), Pacific Biosciences (Danaher Corporation) (U.S.), Thermo Fisher Scientific Inc. (U.S.), Qiagen N. V. (Germany), Beijing Genomics Institute (China), PerkinElmer, Inc (U.S.), F. Hoffmann La Roche AG (Switzerland), Genomatix GmbH (Germany), Oxford Nanopore Technologies (U.K.), and Eurofins Scientific (U.S.) to name a few.

In June 2017, FDA approved Illumina’s next-generation sequencing cancer companion diagnostic test kit, which was developed together with Amgen

In April 2016, Oxford Nanopore Technology released a USB 3.0-interfaced sequencer, the MinION a newer method for multiplexed target enrichment of NGS libraries using the PCR-generated baits

In May 2015, Pacific Biosciences and RainDance Technologies partnered to co-develop and commercialize novel solution for De Novo whole genome assembly

REPORT OUTLINE:

• The report provides granular level information about the market size, regional market share and forecast from 2017-2023
• The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
• The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
• The report tracks recent innovations, key developments and startup’s details that are working in the industry
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET INTRODUCTION

2.1. Global Next Generation Sequencing (NGS) Market – Taxonomy
2.2. Global Next Generation Sequencing (NGS) Market –Definitions
  2.2.1. Type
  2.2.2. Technology
  2.2.3. Application
  2.2.4. End User

3. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Next Generation Sequencing (NGS) Market Dynamics – Factors Impact Analysis
3.6. Global Next Generation Sequencing (NGS) Market – Regulations
  3.6.1. U.S
  3.6.2. Europe
  3.6.3. Japan
  3.6.4. China
3.7. Global Next Generation Sequencing (NGS) Market – Product Innovations

4. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Products
  5.1.1. Instruments & Software
  5.1.2. Consumables
    5.1.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
5.2. Services
  5.2.1. Sequencing services
  5.2.2. Dataa Analysis Services
    5.2.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
    5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  5.2.3. Market Opportunity Analysis

6. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET FORECAST, BY TECHNOLOGY, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Whole Targeted Re-sequencing
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.1.3. Market Opportunity Analysis
6.2. Whole Genome Sequencing
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.2.3. Market Opportunity Analysis
6.3. Transcriptome (RNA-Seq)
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.3.3. Market Opportunity Analysis
6.4. Whole Exome Sequencing
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.4.3. Market Opportunity Analysis
6.5. De Novo Sequencing
  6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.5.3. Market Opportunity Analysis
6.6. ChiP Sequencing
  6.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.6.3. Market Opportunity Analysis
6.7. Methylation Sequencing
  6.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.7.3. Market Opportunity Analysis
6.8. Others
  6.8.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  6.8.3. Market Opportunity Analysis

7. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Diagnostics
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.1.3. Market Opportunity Analysis
7.2. Drug Discovery & Development
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.2.3. Market Opportunity Analysis
7.3. Biomarker Discovery
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.3.3. Market Opportunity Analysis
7.4. Agriculture & Animal Health Research
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.4.3. Market Opportunity Analysis
7.5. Personalised Medicine
  7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  7.5.3. Market Opportunity Analysis

8. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Academic Institutes & Research Centers
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.1.3. Market Opportunity Analysis
8.2. Hospital/Clinical Laboratories
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.2.3. Market Opportunity Analysis
8.3. Biotech/Pharmaceuticals Companies
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.3.3. Market Opportunity Analysis
8.4. Others
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  8.4.3. Market Opportunity Analysis

9. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. North America
  9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.1.3. Market Opportunity Analysis
9.2. Europe
  9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
  9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.3.3. Market Opportunity Analysis
9.4. Latin America
  9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.4.3. Market Opportunity Analysis
9.5. MEA
  9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  9.5.3. Market Opportunity Analysis
9.7. Global Next Generation Sequencing (NGS) Market - Opportunity Analysis Index, By Product Type, Technology, Application, and Region, 2017 – 2023

10. NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  10.1.1. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    10.1.1.1. Products
      10.1.1.1.1. Instruments & Software
      10.1.1.1.2. Consumables (Reagents & kits)
    10.1.1.2. Services
      10.1.1.2.1. Sequencing Services
      10.1.1.2.2. Data Analysis Services
  10.1.2. Technology Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.2.1. Whole Targeted Re-sequencing
    10.1.2.2. Whole Genome Sequencing
    10.1.2.3. Transcriptome (RNA-Seq)
    10.1.2.4. Whole Exome Sequencing
    10.1.2.5. De Novo Sequencing
    10.1.2.6. ChiP Sequencing
    10.1.2.7. Methylation Sequencing
    10.1.2.8. Others
  10.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.3.1. Diagnostics
    10.1.3.2. Drug Discovery & Development
    10.1.3.3. Biomarker Discovery
    10.1.3.4. Agriculture & Animal Health Research
    10.1.3.5. Personalised Medicine
  10.1.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.4.1. Academic Institutes & Research Centers
    10.1.4.2. Hospital/Clinical Laboratories
    10.1.4.3. Biotech/Pharmaceuticals Companies
    10.1.4.4. Others
  10.1.5. North America Next Generation Sequencing Market - Opportunity Analysis Index, By Product Type, Technology, Application, and Country, 2017 – 2023
  10.1.6. North America Next Generation Sequencing Market Dynamics – Trends

11. EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

12. ASIA-PACIFIC NEXT GENERATION SEQUENCING (NGS) MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

13. LATIN AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

14. MEA NEXT GENERATION SEQUENCING (NGS) MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

16. COMPETITION LANDSCAPE

16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  16.2.1. Agilent Technologies Inc.
  16.2.2. BGI (Beijing Genomics Institute)
  16.2.3. Biomatters Ltd.
  16.2.4. DNASTAR Inc.
  16.2.5. GATC Biotech Ag
  16.2.6. Genomatix Software GmbH
  16.2.7. Illumina Incorporated
  16.2.8. Knome Inc.
  16.2.9. Life Sciences (Roche)
  16.2.10. Macrogen Inc.
  16.2.11. Oxford Nanopore Technologies Ltd.
  16.2.12. Pacific Biosciences
  16.2.13. Partek Inc.
  16.2.14. Perkin Elmer Inc.
  16.2.15. Qiagen N.V
  16.2.16. Thermo Fischer Scientific

17. RESEARCH METHODOLOGY

18. KEY ASSUMPTIONS AND ACRONYMS